Phase II Study of Perindopril and Regorafenib in mCRC

NCT02651415 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Regorafenib
DRUG: Perindopril

Sponsor

British Columbia Cancer Agency

Collaborators

[object Object]